Novolog Mix 70 / 30 (Insulin Aspart Protamine Suspension / Insulin Aspart Injection) - Summary

SUMMARY

NovoLog^® Mix 70/3070% insulin aspart protamine suspension and 30% insulin aspart injection, (rDNA origin)

NovoLog Mix 70/30 (70% insulin aspart protamine suspension and 30% insulin aspart injection, [rDNA origin]) is a human insulin analog suspension containing 70% insulin aspart protamine crystals and 30% soluble insulin aspart. NovoLog Mix 70/30 is a blood glucose-lowering agent with a rapid onset and an intermediate duration of action. Insulin aspart is homologous with regular human insulin with the exception of a single substitution of the amino acid proline by aspartic acid in position B28, and is produced by recombinant DNA technology utilizing Saccharomyces cerevisiae (baker's yeast) as the production organism.

NovoLog Mix 70/30 is indicated for the treatment of patients with diabetes mellitus for the control of hyperglycemia.

NEWS HIGHLIGHTS RELATED TO NOVOLOG MIX 70 / 30

Published Studies Related to Novolog Mix 70 / 30 (Insulin Aspart Protamine Suspension / Insulin Aspart Injection)

Postprandial versus preprandial dosing of biphasic insulin aspart in elderly type 2 diabetes patients. [2004.10]

A direct efficacy and safety comparison of insulin aspart, human soluble insulin, and human premix insulin (70/30) in patients with type 2 diabetes. [2004.05]

Randomized, multinational, open-label, 2-period, crossover comparison of biphasic insulin aspart 30 and biphasic insulin lispro 25 and pen devices in adult patients with type 2 diabetes mellitus. [2004.04]

A multicenter, randomized, open-label, comparative, two-period crossover trial of preference, efficacy, and safety profiles of a prefilled, disposable pen and conventional vial/syringe for insulin injection in patients with type 1 or 2 diabetes mellitus. [2003.11]

Pharmacokinetics and pharmacodynamics of a premixed formulation of soluble and protamine-retarded insulin aspart. [2000.08]

more>>

Clinical Trials Related to Novolog Mix 70 / 30 (Insulin Aspart Protamine Suspension / Insulin Aspart Injection)

Comparison of Insulin Detemir, Insulin Aspart and Biphasic Insulin Aspart 30 With OAD Treatment in Type 2 Diabetes [Active, not recruiting]

A Study to Evaluate the Effect of Nasal Insulin on Postprandial Glycemic Control in Type 2 Diabetic Patients [Completed]

Efficacy and Safety of Insulin Detemir in Combination With Insulin Aspart and Biphasic Insulin Aspart 30 in Type 2 Diabetes [Completed]

A Comparison of Pharmacodynamics and Pharmacokinetics of Insulin Aspart, Biphasic Insulin Aspart 30, 50 and 70. [Completed]

Comparison of Insulins Aspart and Lispro in Insulin Pumps [Active, not recruiting]

more>>